Companies › DTIL

PRECISION BIOSCIENCES INC (DTIL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001357874 · EDGAR filings · Updated 2026-07-27

PRECISION BIOSCIENCES INC (DTIL) has reported institutional ownership of 65.3%, with 78 institutional managers holding positions valued at $88.1M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Filings this week (1)

• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — SCHEDULE 13G filed
• 2026-07-01 — Current report (8-K) filed
• 2026-06-16 — Current report (8-K) filed
• 2026-06-05 — Insider transaction reported (Form 4)
• 2026-06-05 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PRECISION BIOSCIENCES INC has 78 institutional holders and institutional ownership of 65.3%.

Insider activity

Insiders reported 43 transactions (7 buys, 12 sells) across 9 reporting insiders, with a net reported value of −$447.3K.

Data flags from SEC filings

Related companies

MEDIWOUND LTD (MDWD) · KORU MEDICAL SYSTEMS INC (KRMD) · FATE THERAPEUTICS INC (FATE) · OMNIAB INC (OABI) · TILRAY BRANDS INC (TLRY) · SIGHT SCIENCES INC (SGHT)